Incubation period of infectious diseases

Incubation and observation in the focus (using epidemic typhus as an example)

The duration of the incubation period directly determines the timeline of medical observation for contacts in an epidemiological focus. Upon identifying a patient with epidemic typhus (causative agent — Rickettsia prowazekii), the physician prescribes daily thermometry for contacts. Observation is conducted for the duration of the maximum incubation period, which for this infection is 3 weeks.

Since the infection is vector-borne and transmitted via the body and head louse, disinsection measures are carried out immediately at the outbreak site. The causative agent is capable of forming "dormant" forms that persist for a long time in the external environment (for example, on the patient's body and bed linen), which dictates the strict necessity of also carrying out disinfection. If the first signs of a febrile illness appear in contacts during these three weeks, immediate medical consultation is required, although emergency drug treatment at the prehospital stage is not indicated.

Laboratory changes prior to clinical manifestations

The incubation period is not always an absolute "blind" window for laboratory diagnostics. A number of markers can be detected before the manifestation of the disease:

• EBV infection (infectious mononucleosis): Specific antibodies to the capsid antigen — anti-VCA IgM — appear in the blood as early as the end of the incubation period. They will circulate throughout the course of the disease, gradually declining in the early convalescence period, and completely disappear only by the end of the 6th month. At the same time, the classic cellular marker of the disease — atypical mononuclear cells (wide-cytoplasm basophilic lymphocytes) — appear in peripheral blood only with the onset of clinical manifestations.
• Viral hepatitis A (VHA): In the late incubation period, specific anti-HAV IgM antibodies may already be detected in the patient.

Epidemiological hazard of the patient during the incubation period

A person in the incubation period can pose a serious epidemiological threat. If isolated anti-HAV IgM are detected in an asymptomatic contact in a HAV focus, the physician must perform a differential diagnosis between four states:

1. Late incubation period.
2. Current subclinical form of HAV.
3. Current inapparent form of HAV.
4. Convalescence period following an asymptomatic form.

A biochemical blood test is mandatory to verify the diagnosis. If enzymemia (elevated transaminases) is detected alongside normal bilirubin values, this points to a subclinical form or late incubation. At this stage, the patient is already actively shedding the virus and is a source of infection.

Management tactics in such cases require dynamic biochemical monitoring and mandatory hospitalization in an infectious diseases hospital. The decision to hospitalize here is dictated not by the severity of the condition (there are no clinical manifestations yet), but by epidemiological indications — for example, if the patient lives in crowded conditions (a dormitory), in order to break the chain of virus transmission.

Class and exam questions

What else to study on this topic

• Pathogenesis of lifelong rickettsial persistence and the development of Brill-Zinsser disease
• Dynamics of serological markers in EBV infection (ELISA and heterohemagglutination assays)
• Differential diagnosis of subclinical and inapparent forms of viral hepatitis A
• Management of cholestatic syndrome in viral hepatitis
• Guidelines for physician practice in an epidemiological focus and documentation management

Other topics in the "Vector-borne infections" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.